Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2019, Article ID 1525646, 8 pages
https://doi.org/10.1155/2019/1525646
Research Article

Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India

1Department of Community Medicine and School of Public Health, Post-Graduate Institute of Medical Education and Research, Chandigarh 160012, India
2Department of Internal Medicine, Post-Graduate Institute of Medical Education and Research, Chandigarh 160012, India
3Department of Immunopathology, Post-Graduate Institute of Medical Education and Research, Chandigarh 160012, India
4Department of Epidemiology and Population Health, The London School of Hygiene and Tropical Medicine, London WC1E7HT, UK
5School of Public Health and Community Medicine, University of New South Wales, Sydney 2033, Australia

Correspondence should be addressed to R. Kumar; ni.ude.remigp@hsejar.ramuk

Received 19 October 2018; Revised 10 January 2019; Accepted 7 February 2019; Published 27 February 2019

Academic Editor: Seble Kassaye

Copyright © 2019 C. K. Chauhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, “2017 Report on global AIDS epidemic,” Geneva, UNAIDS, 2017, http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2017_en.pdf.
  2. NACO, “Anti-retroviral therapy guideline Ministry of Health and Family Welfare New Delhi,” 2018, http://naco.gov.in/sites/default/files/Antiretroviral%20Therapy%20Guidelines%20for%20HIVInfected%20Adults%20and%20Adolescents%20May%202013%281%29_0.pdf.
  3. D. K. Jha, U. K. Ojha, and A. K. Jha, “Outcome of second line anti-retroviral therapy in hiv positive patients,” International Journal of Contemporary Medical Research [IJCMR], vol. 5, no. 9, pp. 1–4, 2018. View at Google Scholar
  4. D. Boden, A. Hurley, L. Zhang et al., “HIV-1 drug resistance in newly infected individuals,” Journal of the American Medical Association, vol. 282, no. 12, pp. 1135–1141, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Pereira-Vaz, V. Duque, L. Trindade, J. Saraiva-da-Cunha, and A. Meliço-Silvestre, “Detection of the protease codon 35 amino acid insertion in sequences from treatment-naïve HIV-1 subtype C infected individuals in the Central Region of Portugal,” Journal of Clinical Virology, vol. 46, no. 2, pp. 169–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Manosuthi, S. Thongyen, S. Nilkamhang, S. Manosuthi, and S. Sungkanuparph, “HIV-1 drug resistance-associated mutations among antiretroviral-naive thai patients with chronic HIV-1 infection,” Journal of Medical Virology, vol. 85, no. 2, pp. 194–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kiertiburanakul and S. Sungkanuparph, “Emerging of HIV drug resistance: Epidemiology, diagnosis, treatment and prevention,” Current HIV Research, vol. 7, no. 3, pp. 273–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. L. Hamers, C. L. Wallis, C. Kityo et al., “HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: A multicentre observational study,” The Lancet Infectious Diseases, vol. 11, no. 10, pp. 750–759, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Dai, S. D. Mahajan, and D. L. Sykes, “Prevalence of transmitted HIV-1 drug resistance (TDR) associated mutations and predicted drug sensitivity in newly diagnosed HIV-1 patient cohort in a Western New York 2005–2011,” Journal of Antivirals Antiretrovirals, vol. 6, no. 1, pp. 022–027, 2005. View at Google Scholar
  10. C. Charpentier, P. Bellecave, M. Cisse et al., “High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger,” Antiviral Therapy, vol. 16, no. 3, pp. 429–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. M. Grant, “Time trends in primary HIV-1 drug resistance among recently infected persons,” Journal of the American Medical Association, vol. 288, no. 2, pp. 181–188, 2002. View at Publisher · View at Google Scholar
  12. L. Vergne, S. Diagbouga, C. Kouanfack et al., “HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon,” Antiviral Therapy, vol. 11, no. 5, pp. 575–579, 2006. View at Google Scholar · View at Scopus
  13. S. K. Arora, S. Gupta, J. S. Toor, and A. Singla, “Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India,” AIDS Research and Human Retroviruses, vol. 24, no. 2, pp. 125–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. D. N. Chaturbhuj, N. K. Hingankar, P. Srikantiah et al., “Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India,” AIDS Research and Human Retroviruses, vol. 26, no. 8, pp. 927–932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Pachamuthu, S. Shanmugam, K. Nagalingeswaran, S. Solomon, and S. Solomon, “HIV-1 drug resistance among untreated patients in India: current status,” Journal of Postgraduate Medicine, vol. 52, no. 3, pp. 183–186, 2006. View at Google Scholar · View at Scopus
  16. M. Lall, R. M. Gupta, S. Sen, K. Kapila, S. P. Tripathy, and R. S. Paranjape, “Profile of primary resistance in HIV-1-infected treatment-naive individuals from western India,” AIDS Research and Human Retroviruses, vol. 24, no. 7, pp. 987–990, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sinha, H. Ahmad, R. C. Shekhar et al., “Prevalence of HIV drug resistance mutations in HIV type 1 isolates in antiretroviral therapy naïve population from northern India,” AIDS Research and Treatment, vol. 2012, Article ID 905823, 6 pages, 2012. View at Publisher · View at Google Scholar
  18. UNAIDS, “WHO working group on global HIV /AIDS and STI surveillance epidemic. when and how to use assays for recent infection to estimate HIV incidence at a population level,” Geneva: UNAIDS, 2013, http://apps.who.int/iris/bitstream/10665/44612/1/9789241501675_eng.pdf.
  19. A. Hauser, C. Santos-Hoevener, K. Meixenberger et al., “Improved testing of recent hiv-1 infections with the biorad avidity assay compared to the limiting antigen avidity assay and bed capture enzyme immunoassay: evaluation using reference sample panels from the german seroconverter cohort,” PLoS ONE, vol. 9, no. 6, p. e 98038, 2014. View at Google Scholar · View at Scopus
  20. Stanford University HIV Drug Resistance Database (HIVDR), https://hivdb.stanford.edu/pages/genotype-phenotype.html. View at Publisher · View at Google Scholar
  21. J. S. Toor, A. Sharma, R. Kumar, P. Gupta, P. Garg, and S. K. Arora, “Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis,” Antiviral Research, vol. 92, no. 2, pp. 213–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Pachamuthu, S. Shanmugam, V. Madhavan et al., “HIVHIV-1 drug resistance among drug-naïve and HAART-treated patients in India: current status,” Regional Health Forum, vol. 15, no. 1, pp. 28–43, 2011. View at Google Scholar
  23. D. E. Bennett, M. Myatt, S. Bertagnolio, D. Sutherland, and C. F. Gilks, “Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment,” Antiviral Therapy, vol. 13, no. 2, pp. 25–36, 2008. View at Google Scholar · View at Scopus
  24. S. Ahumada-Ruiz, D. Flores-Figueroa, I. Toala-González, and M. M. Thomson, “Analysis of HIV-1 pol sequences from Panama: Identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations,” Infection, Genetics and Evolution, vol. 9, no. 5, pp. 933–940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Escoto-Delgadillo, E. Vazquez-Valls, M. Ramirez-Rodriguez et al., “Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico,” HIV Medicine, vol. 6, no. 6, pp. 403–409, 2005. View at Publisher · View at Google Scholar
  26. J. Castillo, G. Arteaga, Y. Mendoza et al., “HIV transmitted drug resistance in adult and pediatric populations in Panama,” Revista Panamericana de Salud Pública/Pan American Journal of Public Health, vol. 30, no. 6, pp. 649–656, 2011. View at Publisher · View at Google Scholar
  27. L. Parham, I. L. De Rivera, W. Murillo et al., “Short communication: High prevalence of drug resistance in HIV type 1-infected children born in honduras and Belize 2001 to 2004,” AIDS Research and Human Retroviruses, vol. 27, no. 10, pp. 1055–1059, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Lloyd, R. J. O'Connell, N. L. Michael et al., “Prevalence of resistance mutations in HIV-1-infected Hondurans at the beginning of the national antiretroviral therapy program,” AIDS Research and Human Retroviruses, vol. 24, no. 4, pp. 529–538, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Murillo, G. Paz-Bailey, S. Morales et al., “Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras,” Journal of Clinical Virology, vol. 49, no. 4, pp. 239–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Baxter, D. Dunn, E. White et al., “Global HIV-1 transmitted drug resistance in the INSIGHT strategic timing of antiretroviral treatment (START) trial,” HIV Medicine, vol. 16, no. 1, pp. 77–87, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Frentz, C. A. B. Boucher, and D. A. M. C. Van De Vijver, “Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world,” AIDS Reviews, vol. 14, no. 1, pp. 17–27, 2012. View at Google Scholar · View at Scopus
  32. M. Oette, R. Kaiser, M. Daumer et al., “Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing,” Journal of Acquired Immune Deficiency Syndromes, vol. 41, no. 5, pp. 573–581, 2006. View at Publisher · View at Google Scholar
  33. A. Apisarnthanarak, T. Jirayasethpong, C. Sa-Nguansilp et al., “Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand,” HIV Medicine, vol. 9, no. 5, pp. 322–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kiertiburanakul, R. Chaiwarith, S. Sirivichayakul et al., “Comparisons of Primary HIV-1 drug resistance between recent and chronic HIV-1 infection within a sub-regional cohort of asian patients,” PLoS ONE, vol. 8, no. 6, p. e62057, 2013. View at Publisher · View at Google Scholar
  35. W. Murillo, I. Lorenzana de Rivera, J. Albert, M. E. Guardado, A. I. Nieto, and G. Paz-Bailey, “Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America,” Journal of Medical Virology, vol. 84, no. 10, pp. 1514–1521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. NACO, “HIV sentinel surveillance,” Technical Brief, Ministry of Health and Family Welfare, New Delhi, India, 2016-17, http://naco.gov.in/sites/default/files/HIV%20SENTINEL%20SURVEILLANCE_06_12_2017_0.pdf. View at Google Scholar
  37. H. S. Iqbal, S. S. Solomon, V. Madhavan, S. Solomon, and P. Balakrishnan, “Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, southern India,” Journal of the International Association of Physicians in AIDS Care, vol. 8, no. 5, pp. 323–327, 2009. View at Publisher · View at Google Scholar · View at Scopus